Eirini Evangelinos is a rising sophomore at Wellesley College, where she is making significant strides as an undergraduate researcher in the Radhakrishnan Lab. Her current research focuses on the computational design and optimization of Antimicrobial Peptides (AMPs), specifically exploring the properties of Piscidin 3. This...
Eirini Evangelinos is a rising sophomore at Wellesley College, where she is making significant strides as an undergraduate researcher in the Radhakrishnan Lab. Her current research focuses on the computational design and optimization of Antimicrobial Peptides (AMPs), specifically exploring the properties of Piscidin 3. This NIH-funded project aims to enhance the potency and efficacy of mutant AMPs through advanced computational modeling techniques. Eirini employs molecular docking and electrostatics analysis to investigate peptide interactions with DNA, a critical aspect of understanding how these peptides can be engineered for improved therapeutic applications.
Eirini's expertise extends beyond the lab, as she is proficient in biochemical visualization software, which allows her to effectively communicate complex molecular interactions and findings. Her background in neurochemistry and small-molecule chemistry informs her approach to research, particularly in the context of neuroinhibition and its implications for developmental psychology. This interdisciplinary perspective enriches her contributions to the lab and positions her as a valuable team member.
In addition to her research, Eirini is actively involved in student outreach and grant writing, demonstrating her commitment to fostering a collaborative and innovative research environment. Her skills in team management and effective communication ensure that projects run smoothly and that all team members are engaged and informed. As she continues to develop her expertise in computational modeling and peptide design, Eirini is poised to make meaningful contributions to the field of biochemistry and beyond, paving the way for future advancements in antimicrobial therapies.
